Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan plus lisinopril versus lisinopril or valsartan alone for hypertensive patients with microalbuminuria
2004-000186-35Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Valsartan + lisinopril combination, Lisinopril monotherapy and Valsartan monotherapy (3 arms). Primary endpoint: Change in urinary albumin/creatinine ratio from baseline to Week 30. Started Feb 2005; status: completed.
02
Drugs
valsartanlisinopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2004-000186-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000186-35.